Literature DB >> 9557632

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

C Apetrei1, D Descamps, G Collin, I Loussert-Ajaka, F Damond, M Duca, F Simon, F Brun-Vézinet.   

Abstract

We sequenced and phylogenetically analyzed the reverse transcriptase (RT) regions of the pol genes of 14 human immunodeficiency virus type 1 (HIV-1) isolates from Romanian patients, which were classified as subtype F on the basis of env gene structure. The RT sequences showed that the strains clustered phylogenetically and were equidistant from other HIV-1 subtypes as shown by the neighbor-joining and maximum-likelihood methods, allowing us to define HIV-1 subtype F according to the pol classification. The subtype F RT sequences differed from reported group M RT sequences by 10.94% (for nucleotides) and 7.6% (for amino acids). Phenotypic analysis of subtype F susceptibility to three classes of antiretroviral compounds showed an increase in the 50% inhibitory concentration of the tetrahydroimidazo[4,5,1-jk] [1,4]-benzodiazepin-2-(1H)-one and -thione (TIBO) derivate R82913 for one strain which was naturally resistant to this compound. This first report of subtype F pol sequences confirms the perfect correlation between the phylogenetic positions determined by env and pol analyses and suggests that virus variability might influence the efficacy of antiretroviral treatments. This finding warrants a global evaluation of the phenotypic and genotypic susceptibility of HIV-1 subtypes to antiretroviral drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557632      PMCID: PMC109572          DOI: 10.1128/JVI.72.5.3534-3538.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization.

Authors: 
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

3.  HIV-1 group O sensitivity to antiretroviral drugs.

Authors:  D Descamps; G Collin; I Loussert-Ajaka; S Saragosti; F Simon; F Brun-Vézinet
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

4.  Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden.

Authors:  T Leitner; D Escanilla; S Marquina; J Wahlberg; C Broström; H B Hansson; M Uhlén; J Albert
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

5.  Genotypic subtypes of HIV-1 in Cameroon.

Authors:  J N Nkengasong; W Janssens; L Heyndrickx; K Fransen; P M Ndumbe; J Motte; A Leonaers; M Ngolle; J Ayuk; P Piot
Journal:  AIDS       Date:  1994-10       Impact factor: 4.177

Review 6.  Tenth anniversary perspectives on AIDS. HIV: between past and future.

Authors:  G Myers
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

7.  Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil.

Authors:  E C Sabino; E G Shpaer; M G Morgado; B T Korber; R S Diaz; V Bongertz; S Cavalcante; B Galvão-Castro; J I Mullins; A Mayer
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

9.  Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1).

Authors:  S A Seibert; C Y Howell; M K Hughes; A L Hughes
Journal:  Mol Biol Evol       Date:  1995-09       Impact factor: 16.240

10.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.

Authors:  L G Kostrikis; E Bagdades; Y Cao; L Zhang; D Dimitriou; D D Ho
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more
  21 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Authors:  Robert W Shafer; Kathryn Dupnik; Mark A Winters; Susan H Eshleman
Journal:  HIV Seq Compend       Date:  2001

3.  env Gene typing of human immunodeficiency virus type 1 strains on electronic microarrays.

Authors:  N A Saunders; S Alexander; I Tatt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns.

Authors:  A Waléria-Aleixo; A N Martins; M B Arruda; R M Brindeiro; R M Da-Silva; F F Nobre; D B Greco; A Tanuri
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

5.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features.

Authors:  Peter N Fonjungo; Eitel N Mpoudi; Judith N Torimiro; George A Alemnji; Laura T Eno; Esther J Lyonga; John N Nkengasong; Renu B Lal; Mark Rayfield; Marcia L Kalish; Thomas M Folks; Danuta Pieniazek
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

7.  Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.

Authors:  M Mracna; G Becker-Pergola; J Dileanis; L A Guay; S Cunningham; J B Jackson; S H Eshleman
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

8.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

9.  High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis.

Authors:  Emanuele Nicastri; Loredana Sarmati; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Clementina Galluzzo; Marco Montano; Ilaria Uccella; Roberta Amici; Francesca Gatti; Vincenzo Vullo; Ercole Concia; Stefano Vella; Massimo Andreoni
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.

Authors:  Nicaise Ndembi; Awet Abraha; Heather Pilch; Hiroshi Ichimura; Dora Mbanya; Lazare Kaptue; Robert Salata; Eric J Arts
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.